7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Immix Biopharma
(NASDAQ:IMMX) 

IMMX stock logo

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. It is developing IMX-110 that is in Phase Ib/IIa clinical trials for the treatment of soft tissue sarcoma and...

Founded: 2012
IPO Price: $5 (Dec 16, 2021)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Immix Biopharma Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 027.6155.2182.82110.42138.03165.63193.24Thousand
Immix Biopharma Days Receivable Outstanding ttm (DSO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.66-2.28-1.9-1.52-1.14-0.76-0.380
Immix Biopharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -533.46-457.25-381.04-304.83-228.63-152.42-76.210
Immix Biopharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -533.46-457.25-381.04-304.83-228.63-152.42-76.210
Immix Biopharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0138.22276.44414.67552.89691.11829.33967.55
Immix Biopharma P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.37-1.17-0.98-0.78-0.59-0.39-0.20
Immix Biopharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -8.19-7.02-5.85-4.68-3.51-2.34-1.170
Immix Biopharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.841.682.513.354.195.035.86
No extra charts and metrics for this ticker.